US8807861 — Spreading implement
Method of Use · Assigned to Acrux DDS Pty Ltd · Expires 2027-02-26 · 1y remaining
What this patent protects
This patent protects a spreading implement for applying a transdermal lotion to the axilla area of a user.
USPTO Abstract
An implement 1 for applying a volume of liquid to a treatment surface can include a support 3 onto which is mounted a receptacle 2 , the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. A system for transdermal administration of a physiological active agent from a liquid composition and a method of using this system are described.
Drugs covered by this patent
- Androgel (TESTOSTERONE) · Besins Hlthcare
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1563 |
— | Androgel |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.